TMHC | Ticker Profile - Titan Protect

TMHC

Taylor Morrison Home Corporation

Consumer Cyclical · Residential Construction · NYQ

$71.53

Data: 2026-05-28

✓ ETHICAL PASS

Unknown MOAT

HIGH

Data Confidence: 100.0%

Key Metrics

How this company measures up on the fundamentals that matter

Market Cap

$5.5B

Total market value of the company

Trailing P/E

8.73

Very cheap relative to earnings

Forward P/E

9.24

Based on estimated future earnings — lower means cheaper

Rev Growth

-26.8%

Year-over-year revenue change

Profit Margin

8.8%

How much profit the company keeps from each dollar of revenue

ROE

11.1%

Return on equity — how efficiently it uses shareholder money

Analyst Target

$69.00

-4% from current price — median analyst estimate

Recommendation

BUY

Consensus view from 9 analysts covering this stock

About Taylor Morrison Home Corporation

Taylor Morrison Home Corporation, together with its subsidiaries, operates as a homebuilder and land developer in the United States. It designs, builds, and sells single, and multifamily detached and attached homes in markets for entry-level, move-up, and resort lifestyle buyers under the Taylor Morrison and Esplanade brand names; and develops lifestyle and master-planned communities with single, and multi-family detached and attached homes. The company is also involved in the Build-to-Rent homebuilding business under the Yardly brand name; and provision of financial services, title insurance, and closing settlement services. Taylor Morrison Home Corporation was founded in 1936 and is headquartered in Scottsdale, Arizona.

https://www.taylormorrison.com

Country: United States Employees: 2,800 Industry: Residential Construction

Ethical Screening

Five compliance checks based on AAOIFI standards — all must pass for ethical clearance

Business Activity

PASS

Core business does not involve prohibited activities

Debt Ratio

0.0% N/A

Debt must be below 33% of total assets

Cash Ratio

0.0% N/A

Interest-bearing cash below 33% of assets

Receivables

0.0% N/A

Receivables below 49% of assets

Revenue Purity

0.0% PASS

Non-compliant revenue below 5% — any excess requires purification

Quantitative Intelligence

Statistical analysis of price behaviour, risk, and market regime — independent of fundamental data

Regime

MARKDOWN

Price trending down — defensive positioning

Sharpe Ratio

0.231

Positive but modest risk-adjusted returns

Kelly Fraction

0.0167

Marginal edge — very small allocation suggested

Calmar Ratio

0.080

Drawdown risk outweighs the returns — higher risk profile

Annual Return

2.2%

Historical annualised return based on price data

Max Drawdown

-27.9%

Largest peak-to-trough decline — the worst it has been

HMM State

BEAR

Statistical model detects bearish conditions

Days in State

How long the current regime has persisted — longer means more stable

Market Data

Trading characteristics and market positioning

Beta

1.51

Significantly more volatile than the market

52W High

$72.50

1% below the year high

52W Low

$54.15

32% above the year low

Avg Volume

1,228,442

Average daily shares traded — higher means easier to buy and sell

Short Ratio

4.4

Days it would take all short sellers to cover — higher means more crowded

Short % Float

8.2%

Moderate short interest

Div Yield

N/A

Annual dividend as a percentage of the share price

EPS (TTM)

$6.79

Earnings per share over the last 12 months

Financial Health

Balance sheet strength and cash generation — the foundation of long-term value

Debt/Equity

38.65

Heavy leverage — higher financial risk if revenues decline

Current Ratio

9.26

Strong balance sheet — comfortably covers short-term obligations

Quick Ratio

1.04

Like current ratio but excludes inventory — stricter test

Gross Margin

22.6%

Revenue left after cost of goods — higher means pricing power

Operating Margin

11.1%

Profit from core operations before interest and tax

Free Cash Flow

$504M

Positive — the business generates more cash than it spends

Revenue (TTM)

$7.6B

Total revenue over the last 12 months

Net Income

$668M

Profitable — the bottom line is positive

Analyst Coverage

Analysts

Target High

$95.00

Target Median

$69.00

Target Low

$49.00

Explore the Ethical Screener View Track Record

Data sourced from public filings and market feeds. Not financial advice. Updated: 2026-05-28

Before you go